ArticleBritish journal of clinical pharmacology2018

Population pharmacokinetics of the MEK inhibitor selumetinib and its active N-desmethyl metabolite: data from 10 phase I trials.

Parul Patel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.